About Pricing FAQs Providers Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDNANCT02386722

Intervention to Improve Inhalative Adherence

Despite progress in pharmacological and non-pharmacological treatment in recent years, the burden of disease among asthma and COPD patients is high and patients may be frequently hospitalized due to e...

Lead sponsor: Cantonal Hosptal, Baselland•2 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Cantonal Hosptal, Baselland

Collaborators

University of Basel

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Inclusion:
•Aged 18 years or older
•Have an established asthma-diagnosis according to the Global Initiative for Asthma (GINA) guidelines and/or
•Have an established COPD diagnosis according to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines (severity GOLD I-IV based on the international GOLD-Criteria) \[46\] and
•Are prescribed daily inhaled medication (controller medication for a daily maintenance treatment)
•Had at least one exacerbation in the previous 12 months before study start
•With a metered dose Inhaler (e.g. Ventolin®), Diskus (e.g.Seretide®), Turbohaler (e.g.Symbicort®), Aerolizer/Breezhaler (e.g.Onbrez®), HandiHaler (e.g. Spiriva®) or Ellipta (e.g Relvar®)
•Exclusion:
•Suffering from malignancies and/or other severe diseases
•Insufficient in the German language
•Pregnant or lactating

Related studies

Effect of Simeox® on Residual Volume in COPD Patients With Pulmonary Hyperinflation

NCT07665931 · Chronic Obstructive Pulmonary Disease (COPD), Pulmonary Hyperinflation

RECRUITINGPhase 2

A Study of WIN378 in Participants With Moderate to Severe COPD (Sirius)

NCT07646587 · COPD (Chronic Obstructive Pulmonary Disease)

Effects of Laura Mitchell's and Benson Relaxation Technique On Anxiety, Sleep Quality and Fatigue Among COPD Patients

NCT07635446 · COPD

Assess Accuracy of Primary Care Asthma and COPD Diagnosis Using Oscillometry and FeNO vs Specialist Diagnosis

NCT07245576 · Asthma, COPD

Pulmonary Rehabilitation for Rural Patients With COPD

NCT06847061 · Chronic Obstructive Pulmonary Disease (COPD

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: March 4, 2025Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment169

Start dateJan 2014

Last updatedMar 4, 2025

Condition

Chronic Asthma COPD

Locations shown

Cantonal Hospital Baselland Liestal

Liestal, Basel-Landschaft

Cantonal Hospital Baselland

Liestal, Basel-Landschaft

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: March 4, 2025Data synced to Clareo: July 13, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions